Neri, Lane M.

HRN: 09-83-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/25/2025
03/03/2025
IV
500 Mg
Q 8 Hours
Amebiasis
Waiting Final Action 
02/26/2025
CEFTRIAXONE 1G (VIAL)
02/26/2025
03/04/2025
IV
2gm
OD
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: